Specialty
Category Archives: Congenital disorders
Vijay K, Neuen BL, Lerma EV. Heart failure in patients with diabetes and chronic kidney disease: challenges and opportunities. Cardiorenal Med. 2022;12(1):1–10. Article CAS PubMed Google Scholar Fontes-Carvalho R, Santos-Ferreira D, Raz I, Marx N, Ruschitzka F, Cosentino F. Protective effects of SGLT-2 inhibitors across the cardiorenal continuum: two faces of the same coin. Eur […]
Adults with insomnia may have a genetic predisposition to it, according to the results of a new study published in the Journal of Psychology and Psychiatry. According to the findings, the genetic propensity for insomnia can be linked to poor sleep traits as a child. Takeaways Early-life stress alone can have a very negative impact […]
Yvette Wong, PhD, assistant professor in the Ken and Ruth Davee Department of Neurology’s Division of Movement Disorders, was co-lead author of the study published in Proceedings of the National Academy of Sciences. A new Northwestern Medicine study has uncovered previously unidentified intracellular mechanisms in the peripheral nervous system that cause Charcot–Marie–Tooth Type 2B disease, […]
Marsha Weigum was sitting in the office of her doctor in Carbondale when she was told that there was a 99% chance her son would be born with Down syndrome. She’d received a call from her doctor earlier that day asking her to come in about her blood work. “Down syndrome, the word is not […]
Tl;dr: Congenital syphilis is a disease that occurs when a pregnant person passes the infection on to their baby during pregnancy and can be very serious. Rates of congenital syphilis have significantly increased in the last decade. Congenital syphilis can be prevented by finding and treating syphilis in pregnancy. Unfortunately, lack of access to pregnancy […]
From left: Director of the Public Health Department at MoPH Sheikh Dr. Mohammed bin Hamad Al Thani, CEO of Sidra Medicine Dr. Iyabo Tinubu Karch, Director of the GMP facility Dr. Chiara Cugno and Chief Research Officer at Sidra Medicine Dr. Khalid Fakhro during the opening of the Good Manufacturing Practice facility, yesterday. Doha, Qatar: Sidra […]
PRINCETON, N.J.–(BUSINESS WIRE)– Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) approved Augtyro™ (repotrectinib) for the treatment of adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC).1 Administered as an oral therapy, Augtyro is a tyrosine kinase inhibitor (TKI) targeting ROS1 oncogenic fusions.1 The […]